Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Conference News TCT 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Caitlin E. Cox

November 06, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Daily News

Call to Action Issued for CVD Care in Female Military Veterans

Todd Neale

February 21, 2019

News Daily News

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Shelley Wood

October 19, 2016

News Opinion Editor's Corner ESC 2016

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Shelley Wood

September 08, 2016

Presentation ESC 2016

Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation

Presenter: Andreas Goette

August 30, 2016

News Industry News

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

September 14, 2015

News Industry News

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

June 12, 2015

News Daily News

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Salynn Boyles

April 28, 2015

News Daily News

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

Salynn Boyles

April 28, 2015

News Daily News

当将胺碘酮联合华法林使用时，卒中、全身栓塞风险高于阿哌沙班

L.A. McKeown

October 10, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

L.A. McKeown

October 10, 2014

News Daily News

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

L.A. McKeown

October 10, 2014

Presentation

Efficacy and Safety of Apixaban Following Cardioversion for A-fib: ARISTOTLE Insights

Presenter: Greg Flaker

November 14, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Jason Kahn

August 05, 2013

News Daily News

Primed Mesenchymal Stem Cells May Improve Heart Function

Caitlin E. Cox

April 12, 2013

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

What’s Going to Be Hot at AHA 2025?

June 2024 Dispatch for the CV Team

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

Call to Action Issued for CVD Care in Female Military Veterans

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Edoxaban vs Enoxaparin-Warfarin in Subjects UndergoingCardioversion of Atrial Fibrillation

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

Una Gran Minoría de Pacientes con Fibrilación Auricular de Bajo Riesgo Siguen Recibiendo Anticoagulantes

Substantial Minority of Low-Risk A-fib Patients Still Given Anticoagulants

当将胺碘酮联合华法林使用时，卒中、全身栓塞风险高于阿哌沙班

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

Efficacy and Safety of Apixaban Following Cardioversion for A-fib: ARISTOTLE Insights

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Primed Mesenchymal Stem Cells May Improve Heart Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content